GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis

Acta Diabetologica

Volumn 53, Issue 2, 2016, Pages 279-293

  Moran, Brian M ^a   Abdel Wahab, Yasser H A ^a   Vasu, Srividya ^a   Flatt, Peter R ^a   McKillop, Aine M ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

G protein coupled receptor 39; Glucose tolerance; Insulin secretion; Pancreatic beta cells; Trace metals

Indexed keywords

CALCIUM; COBALT; COBALT CHLORIDE; COPPER CHLORIDE; CUPRIC ION; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 39; INSULIN; LACTATE DEHYDROGENASE; NICKEL; NICKEL SULFATE; UNCLASSIFIED DRUG; ZINC CHLORIDE; ZINC ION; ZINC SULFATE; GLUCOSE; GPR39 PROTEIN, MOUSE; TRACE ELEMENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME RELEASE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SECOND MESSENGER; ANIMAL; BLOOD; CELL LINE; DRUG EFFECTS; GENETICS; GLUCOSE INTOLERANCE; HOMEOSTASIS; HYPERGLYCEMIA; METABOLISM; PHYSIOLOGY;

ANIMALS; CALCIUM; CELL LINE; CYCLIC AMP; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; MICE; RECEPTORS, G-PROTEIN-COUPLED; TRACE ELEMENTS;

EID: 84933563951     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-015-0781-5     Document Type: Article

References (52)

1. Tremblay F, Perreault M, Klaman LD, Tobin JE, Smith E, Gimeno RE (2007) Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 148:501–506
2. Holst B, Holliday ND, Bach A, Elling CE, Cox HM, Schwartz TM (2004) Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 279:53806–53817
3. Egerod KL, Holst B, Petersen PS, Hansen JB, Mulder J, Hokfelt T, Schwartz TW (2007) GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver and white adipose tissue. Mol Endocrinol 21:1685–1698
4. McKee KK, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk DL, Smith RG, Howard AD, Van der Ploeg LH (1997) Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to growth hormone secretagogue and neurotensin receptors. Genomics 46:426–434
5. Catalan V, Gomez-Ambrosi J, Rotellar F, Silva C, Gil MJ, Rodriquez A, Cienfuegos JA, Salvador J, Fruhbeck G (2007) The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus. Clin Endocrinol 66:598–601
6. Egerod KL, Jin C, Petersen PS, Wierup N, Sundler F, Holst B, Schwartz TW (2011) β- cell specific overexpression of GPR39 protects against streptozotocin-induced hyperglycaemia. Int J Endocrinol 2011:1–8
7. Holst B, Egerod KL, Jin C, Petersen PS, Ostergaard MV, Hald J, Sprinkel AM, Storling J, Mandrup-Poulsen T, Holst JJ et al (2009) G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction. Endocrinology 150:2577–2585
8. Xie F, Lui H, Zhu Y, Qin YR, Dai Y, Zeng T, Chen L, Nie C, Tang H, Li Y et al (2011) Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma. BMC Cancer 11:1–12
9. Zhang JV, Ren P, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 310:996–999
10. Holst B, Egerod KL, Schild E, Vickers SP, Cheetham S, Gerlach LO, Storjohann L, Stidsen CE, Jones R, Beck-Sickinger AG et al (2007) GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148:13–20
11. Gourcerol G, St-Pierre DH, Tache Y (2007) Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? Regul Pept 141:1–7
12. Kobelt P, Wisser AS, Stengel A, Goebel M, Bannert N, Gourcerol G, Inhoff T, Noetzel S, Wiedenmann B, Klapp BF et al (2008) Peripheral obestatin has no effects on feeding behaviour and brain Fos expression in rodents. Peptides 29:1018–1027
13. Andersson T, Berggren PO, Flatt PR (1980) Subcellular distribution of zinc in islet β-cell fractions. Horm Metab Res 12:275–276
14. Petersen PS, Jin C, Madsen AN, Rasmussen M, Kuhre R, Egerod KL, Nielsen LB, Schwartz TW, Holst B (2011) Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism. FASEB J 25:3803–3814
15. Kelleher SL, McCormick NH, Velasquez V, Lopez V (2011) Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland. Adv Nutr 2:101–111
16. 2+ -activated G-protein coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol Life Sci 68:85–95
17. Holst B, Elling CE, Schwartz TW (2002) Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors. J Biol Chem 277:47662–47670
18. Ohly P, Dohle C, Abel J, Seissler J, Gleichmann H (2000) Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 43:1020–1030
19. Huber AM, Gershoff SN (1973) Effect of zinc deficiency in rats on insulin release from the pancreas. J Nutr 103:1739–1744
20. Chen MD, Liou SJ, Lin PY, Yang VC, Alexander PS, Lin WH (1998) Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Bio Trace Elem Res 61:303–311
21. Depoortere I (2012) GI functions of GPR39: novel biology. Curr Opin Pharmacol 12:647–652
22. Moechars D, Depoortere I, Moreaux B, de Smet B, Goris I, Hoskens L, Daneels G, Kass S, Ver Donck L, Peeters T et al (2006) Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor knockout mouse. Gastroenterology 131:1131–1141
23. Gault VA, Porter WD, Flatt PR, Holscher C (2010) Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high fat diet. In J Obes 34:1341–1344
24. Porter DW, Kerr BD, Flatt PR, Holscher C, Gault VA (2010) Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with dietary-induced obesity and insulin resistance. Diabetes Obes Metab 12:891–899
25. Besser L, Chorin E, Sekler I, Silverman WF, Atkin S, Russell J, Hershfinkel M (2009) Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J Neurosci 29:2890–2901
26. Dittmer S, Sahin M, Pantlen A, Saxena A, Toutzaris D, Pina AL, Geerts A, Golz S, Methner A (2008) The constitutively active orphan G-protein-coupled receptor GPR39 protects from cell death by increasing secretion of pigment epithelium-derived growth factor. J Biol Chem 283:7074–7081
27. Mlyneic K, Budziszewska B, Reczynski W, Sowa-Kucma M, Nowak G (2013) The role of the GPR39 receptor in zinc deficient-animal model of depression. Behav Brain Res 238:30–35
28. Cole TB, Robbins CA, Wenzel HJ, Schwartzkroin PA, Palmiter RD (2000) Seizures and neuronal damage in mice lacking vesicular zinc. Epilepsy Res 39:153–169
29. Sun SW, Won SJ, Hamby AM, Yoo BH, Fan Y, Sheline CT, Tamano H, Takeda A, Liu J (2009) Decreased brain zinc availability reduced hippocampal neurogenesis in mice and rats. J Cereb Blood Flow Metab 29:1579–1588
30. 2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair. J Biol Chem 285:26097–26106
31. McClenaghan NH, Barnett CR, Ah-Sing E, Abdel-Wahab YH, O’Harte FP, Yoon TW, Swanston-Flatt SK, Flatt PR (1996) Characterisation of a novel glucose-responsive insulin-secreting cell line, BRIN BD11, produced by electrofusion. Diabetes 45:1132–1140
32. Flatt PR, Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 20:573–577
33. Moskalewski S (1969) Studies on the culture and transplantation of isolated islets of Langerhans of the guinea pig. Proc K Ned Akad Wet C 72:157–171
34. Bailey CJ, Flatt PR (1982) Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice. Int J Obes 6:11–21
35. Hannan JMA, Marenah L, Ali L, Rokeya B, Flatt PR, Abdel-Wahab YHA (2006) Ocimum sanctum leaf extracts stimulate insulin secretion from perfused pancreas, isolated islets and clonal pancreatic β-cells. J Endocrinol 189:127–136
36. Miguel JC, Patterson S, Abdel-Wahab YHA, Mathias PC, Flatt PR (2004) Time-correlation between membrane depolarization and intracellular calcium in insulin secretion BRIN-BD11 cells: studies using FLIPR. Cell Calcium 36:43–50
37. Moran BM, Abdel-Wahab YH, Flatt PR, McKillop AM (2014) Evaluation of the insulin releasing and glucose lowering effects of GPR120 activation in pancreatic beta cells. Diabetes Obes Metab 16:1128–1139
38. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160:1577–1579
39. Vangaveti V, Shashidhar V, Jarrod G, Baune BT, Kennedy RL (2010) Free fatty acid receptors: emerging targets for treatment of diabetes and its complications. Ther Adv Endocrinol Metab 1:165–175
40. Bailey CJ (2005) Drugs on the horizon for diabesity. Curr Diabet Rep 5:353–359
41. Burant CF (2013) Activation of GPR40 as a therapeutic target for the treatment of type 2 diabetes. Diabetes Care 36:S175–S179
42. Cohen L, Azriel-Tamir H, Arotsker N, Sekler I, Hershfinkel M (2012) Zinc sensing receptor signalling, mediated by GPR39, reduces butyrate-induced cell death in HT29 colonocytes via upregulation of clusterin. PloS One 7:e35482
43. Tremblay F, Richard A, Will S, Syed J, Stedman N, Perreault M, Gimeno RE (2009) Distribution of G-protein-coupled receptor 39 impairs insulin secretion in vivo. Endocrinology 150:2586–2595
44. Rutter GA (2010) Think zinc: new roles for zinc in the control of insulin secretion. Islets 2:49–50
45. Lodemann U, Einspanier R, Scharfen F, Martens H, Bondzio A (2013) Effects of zinc on epithelial barrier properties and viability in a human and a porcine intestinal cell culture model. Toxicol In Vitro 27:834–843
46. Flatt PR, Rorsman P, Swanston-Flatt SK (1987) Effect of cationic modifications on superficial binding and intracellular 45Ca uptake by decapsulated ob/ob mouse pancreatic islets. Biomed Res 8:153–159
47. + channels. J Physiol 529:723–734
48. 4 receptor. J Neurosci 74:1529–1537
49. Fraga CG (2005) Relevance, essentiality and toxicity of trace elements in human health. Mol Asp Med 26:235–244
50. Tanaka T, Yano T, Adachi T, Koshimizu TA, Hirasawa A, Tsujimoto G (2008) Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells. N-S Arch Pharmacol 377:515–522
51. Lauffer LM, Iakoubov R, Brubaker PL (2009) GPR119 is essential for oleoylethanolamide–induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cells. Diabetes 58:1058–1066
52. Adachi Y, Yoshida J, Kodera Y, Kiss T, Jakusch T, Enyedy EA, Yoshikawa Y, Sakurai H (2006) Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Biochem Biophys Res Commun 351:165–170